From 3 credits/hr
Available for pro bono
You won't be charged until confirming
Washington D.C., United States (U.S)
Speaks English

An expert in risk and behavioral science

Dr. Sweta Chakraborty is recognized as an evidence-based, expert communicator who helps household decision-makers better understand existing and emerging risks to be better prepared to thrive on a rapidly changing planet. From climate change, food and water insecurity and scarcity, social strife, over-population, and pandemics, Dr. Chakraborty is the rational, authoritative voice in the media to learn the truth about, implications of, and the solutions to the risks that threaten human security and well-being. Dr. Sweta Chakraborty is a risk and behavioral scientist whose work is motivated by the need for clear, credible, evidence-based communication to urgently and proactively manage the risks that threaten human security and well-being. She is the founder and principle of Adapt to Thrive, a venture that seeks to better inform the public, businesses, and government entities on the complex, interconnected challenges, such as food security and disease, already existing and emerging from a warming planet.
Questions I can answer:
How do I align risk perception to risk reality?
How do I better communicate risks?
How do effectively communicate to different stakeholders in my business?



Experience
Atlantic Council

2019/2020 Millenium Leadership Program Fellow

2019 - Present (2 years, 2 months)
The Millennium Fellowship has become one of the most competitive and highly sought-after programs in the world for future leaders (ages twenty-five to thirty-five) in the international affairs field. The 2019/2020 class of twenty-one was selected from nearly 1,200 applicants from over 100 countries – a 1.75% acceptance rate.
Adapt to Thrive

Founder and Principal

2019 - Present (2 years, 5 months)
Adapt to Thrive seeks to better inform individuals, businesses, and government entities on the complex, interconnected risks and hazards existing and emerging from a warming planet. This is accomplished through innovative communication methods including interactive live stage events, virtual collaborative webinars, and other public engagement efforts to ensure a future that is sustainable and thriving.
We Don't Have Time

US Representative

2018 - Present (2 years, 8 months)
We Don't Have Time aims to create a social media platform for the future, focused on the biggest challenge of our times — the climate. Through our platform, millions of members will unite to put pressure on leaders, politicians and corporations to act for the climate.
America Adapts

Advisory Board Member

2018 - Present (2 years, 8 months)
Board member for "American Adapts, The Climate Change Podcast
The Center for Climate and Security

Host, The Climate and Security Podcast

2018 - Present (3 years, 4 months)
Host of the "The Climate and Security" Podcast
Serendipity Foundation

Member Board of Directors

2018 - Present (3 years, 5 months)
Serendipity Foundation provides funding for non-profit organizations all over the world effecting positive change. We disperse our funds into four sectors: earth, animals, people and culture. These are usually inclusive of organizations dealing with disaster preparation and survival, social injustice, wrongful incarceration, gender/sexuality/race/religious inequality and/or violence, addiction/recovery issues, global climatic management, and worldwide education promotion.
Institute on Science for Global Policy

Associate Director

2015 - 2018 (3 years, 1 month)
Oversee all aspects of the institute, which aims to bring together distinguished scientists and policy makers from governments around the world to discuss scientifically credible options for addressing key public policy topics impacted by science and technology.
Lootok, Ltd.

Cognitive Behavioral Scientist

2014 - 2014 (12 months)
Was responsible for overseeing research and development at risk management consulting firm to ensure the development of all materials and deliverables align with in-house research, as well as the wider discipline of social and decision science. Designed and develop a communication methodology and services line, pitching directly to the C-suite and executive levels of Fortune 100 global companies. Conducted research and publish regularly to position Lootok Ltd. as a leading firm with a cognitive behavioural approach and serve as project lead on accounts ranging from 50K to 6 million USD for Fortune 100 global clients (e.g., Mars Inc., Novartis, PVH Corp.).
University of Oxford

Post Doctoral Fellow

2011 - 2015 (4 years, 8 months)
Post-Doctoral Fellow in the Centre for Socio-Legal working on Research Project on Pharmaceutical Regulation and Product Liability. The project aims to examine the influence and consequences of regulatory and liability mechanisms on decision-making on product safety in the pharmaceutical sector in the EU since around 1970.
EJRR

Risk Consultant

2010 - 2011 (1 year, 12 months)
Contribute and peer review risk communication contributions for the journal for publication
Indiana University

Summer School Professor

2009 - 2012 (3 years, 1 month)
Will co-teach 6-credit course titled Managing Hazards in Europe and the United States I and II from 4-29 July 2011 for 49 undergraduate and graduate summer school students. Previosly in 2009 worked closely with Dean John Graham to execute first visiting summer school program at Kings College London.
King's Centre for Risk Management

Teaching and Research Assistant

2006 - 2010 (3 years, 11 months)
We will continue to focus on world-leading education, research and service and will have an increasingly proactive role to play in a more interconnected, complex world;;
We will continue to expand the huge contribution King’s makes to London and through that a national contribution within the UK, and beyond that to an international community that serves the world.
Pfizer

Healthcare Representative

2002 - 2005 (3 years, 3 months)
Pfizer Inc. is an American multinational pharmaceutical corporation headquartered in New York City. It is one of the world's largest pharmaceutical companies. It is listed on the New York Stock Exchange, and its shares have been a component of the Dow Jones Industrial Average since 2004.

Education
Postdoctorate, Centre for Socio Legal Studies

University of Oxford

2011 - 2013
Ph.D., Behavioral Science

Kings College London

2006 - 2010
Advanced research training and application of cognitive behavioral science in the healthcare/biotech sectors
BSc. , Decision Science

Carnegie Mellon University

2002 - 2006